NewEffaclar
Astringent Lotion
EFFACLAR micro-exfoliating astringent lotion helps instantaneously reduce pore size and fight against blockage, thanks to the combination of sebum-regulating, purifying and micro-exfoliating LHA active ingredients.
The pores are tightened, the skin texture is finer and more even.
200 ml bottle
Buy Now
Properties
For oily skin with imperfections.
Formula enriched with sebo-regulating active ingredients and LHA: Helps to immediately reduce pore size and to fight against their obstruction.
Product efficacy
After 4 weeks, skin is more comfortable 75%*
*57 women,18 to 35 y.o
Texture & application
Fresh lotion. Apply mornings and evenings to the face using a soaked cotton ball, after cleansing and drying the skin.
Skin Diagnosis
DISCOVER EFFACLAR SPOTSCAN
Article
Why is it important to cleanse acne-prone skin before going to bed?
article
Cleaning oily skin requires particular care
La Roche-Posay recommends
Your Effaclar routine
The right gestures for your skin.
Ingredients
Soothing and anti-oxidant effects.
A reference moisturizing molecule for a hydrate-as-you-cleanse glide.
Micro-exfoliates without irritating.
Our safety commitments
Safety standards beyond international cosmetics regulations.
100% products
allergy tested
100% products
allergy tested
One prerequisite = Zero allergic reactions.
If we detect a single case, we go back to the labs and reformulate.
Just the essential,
at the right active dose
Just the essential,
at the right active dose
Developed in collaboration with dermatologists
and toxicologists, our products contain only the necessary
ingredients, at the right active dose.
Tested
on very sensitive skin
Tested
on very sensitive skin
Our products’ tolerance is verified on the most sensitive skin:
reactive, allergic, acne-prone, atopic, damaged or weakened
by cancer treatments.
Formula protection
over time
Formula protection
over time
We select the most protective packaging associated with only
the necessary preservatives, to guarantee intact tolerance
and efficacy over time.